HER2 Therapy Market Demand: Expanding Use of Targeted Therapies in HER2-Positive Cancer
The HER2 therapy market is projected to grow from USD 16.8 billion in 2026 to USD 38.7 billion by 2036, registering a CAGR of 8.7%, according to Future Market Insights. The market is gaining momentum as advances in biomarker testing expand treatment eligibility and pharmaceutical companies develop targeted therapies for HER2-positive, HER2-low, and HER2-ultralow cancers. The market is expected...
0 Comentários 0 Compartilhamentos 3 Visualizações 0 Anterior